S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   191.69 (-0.96%)
AAPL   236.41 (+0.48%)
FB   185.85 (-2.38%)
MSFT   137.41 (-1.63%)
GOOGL   1,244.41 (-0.67%)
AMZN   1,757.51 (-1.68%)
CGC   20.21 (-2.65%)
NVDA   190.49 (-1.96%)
BABA   169.13 (-4.37%)
TSLA   256.95 (-1.92%)
AMD   30.97 (-0.55%)
BAC   30.35 (+0.30%)
GILD   64.91 (-0.49%)
S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   191.69 (-0.96%)
AAPL   236.41 (+0.48%)
FB   185.85 (-2.38%)
MSFT   137.41 (-1.63%)
GOOGL   1,244.41 (-0.67%)
AMZN   1,757.51 (-1.68%)
CGC   20.21 (-2.65%)
NVDA   190.49 (-1.96%)
BABA   169.13 (-4.37%)
TSLA   256.95 (-1.92%)
AMD   30.97 (-0.55%)
BAC   30.35 (+0.30%)
GILD   64.91 (-0.49%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Oncomed PharmaceuticalsAEterna ZentarisProteostasis TherapeuticsBio-PathVital Therapies
SymbolN/ANASDAQ:AEZSNASDAQ:PTINASDAQ:BPTHN/A
Price Information
Current PriceN/A$1.07$0.73$10.99N/A
52 Week RangeHoldBuyBuyBuyN/A
Analyst Ratings
Consensus RecommendationHoldBuyBuyBuyN/A
Consensus Price Target$1.50$2.50$11.33$28.00N/A
% Upside from Price Target∞ upside133.64% upside1,452.51% upside154.78% upsideN/A
Trade Information
Market Cap$34.43 million$22.26 million$37.84 million$31.39 million$35.17 million
Beta1.861.08-0.583.213.51
Average Volume768,904215,2031,162,1291,366,62421,618,420
Sales & Book Value
Annual Revenue$44.42 million$26.90 million$2.84 million$40,000.00N/A
Price / Sales0.000.7913.14792.38N/A
CashflowN/A$0.27 per shareN/AN/AN/A
Price / CashN/A3.96N/AN/AN/A
Book Value$1.25 per share$0.12 per share$2.25 per share$1.79 per share$0.29 per share
Price / Book0.008.920.326.14N/A
Profitability
Net Income$-8,100,000.00$4.19 million$-61,830,000.00$-8,580,000.00$-41,470,000.00
EPS($0.16)$0.25($1.61)($14.38)N/A
Trailing P/E RatioN/A4.28N/AN/A0.00
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-18.24%-536.79%N/AN/AN/A
Return on Equity (ROE)-13.14%-1,428.66%-83.00%-84.81%-235.33%
Return on Assets (ROA)-7.73%-40.36%-65.00%-76.39%-182.35%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A0.15%0.02%N/A
Current Ratio5.04%1.68%8.19%18.01%6.97%
Quick Ratio5.04%1.60%8.19%18.01%6.97%
Ownership Information
Institutional Ownership Percentage45.16%7.03%44.64%9.48%15.52%
Insider Ownership Percentage20.32%N/A19.80%8.65%33.90%
Miscellaneous
Employees22N/A48810
Shares Outstanding38.69 million19.96 million51.13 million2.88 million42.37 million
Next Earnings DateN/A11/5/2019 (Estimated)11/5/2019 (Estimated)11/21/2019 (Estimated)N/A
OptionableOptionableOptionableOptionableNot OptionableOptionable
 Oncomed PharmaceuticalsAEterna ZentarisProteostasis TherapeuticsBio-PathVital Therapies

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel